Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl

Elena Palmisani, Sebastiano Barco, Giuliana Cangemi, Cristina Moroni, Carlo Dufour, Elio Castagnola

Research output: Contribution to journalArticlepeer-review

Abstract

This case report indicates the usefulness of voriconazole for the treatment of central nervous system (CNS) aspergillosis, also in paediatrics. However, it also confirms the need for therapeutic drug monitoring (TDM), especially in younger children that may require very high dosages in order to achieve plasma and cerebrospinal fluid (CSF) therapeutic concentrations.

Original languageEnglish
Pages (from-to)42-44
Number of pages3
JournalJournal of Chemotherapy
Volume29
Issue number1
DOIs
Publication statusPublished - Feb 2017

Keywords

  • Antifungal Agents
  • Antineoplastic Agents
  • Female
  • Humans
  • Immunocompromised Host
  • Infant
  • Neuroaspergillosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Voriconazole
  • Case Reports
  • Journal Article

Fingerprint

Dive into the research topics of 'Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl'. Together they form a unique fingerprint.

Cite this